We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
186 hedge funds and large institutions have $171M invested in Esperion Therapeutics in 2025 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 57 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 57
2% less funds holding
Funds holding: 189 → 186 (-3)
6.7% less ownership
Funds ownership: 64.11% → 57.41% (-6.7%)
11% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 28
38% less capital invested
Capital invested by funds: $278M → $171M (-$106M)
63% less call options, than puts
Call options by funds: $496K | Put options by funds: $1.36M
Holders
186
Holders Change
-3
Holders Change %
-1.59%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
25
Increased
56
Reduced
57
Closed
28
Calls
$496K
Puts
$1.36M
Net Calls
-$862K
Net Calls Change
-$1.96M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$6.69M |
| 2 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$3.69M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$2.04M |
| 4 |
TSC
Two Seas Capital
Rye,
New York
|
+$1.29M |
| 5 |
Squarepoint
New York
|
+$992K |
Top Sellers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$25M |
| 2 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
-$2.87M |
| 3 |
Goldman Sachs
New York
|
-$2.26M |
| 4 |
Two Sigma Advisers
New York
|
-$2.01M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$1.85M |
